Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Onzeald
Onzeald
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Sat, 11/25/17 - 12:29 pm
Nektar
AstraZeneca
Movantik
Onzeald
UCB Pharma
Cimzia
Amgen
Neulasta
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall
Endpoints
Sat, 07/22/17 - 09:57 am
Nektar
regulatory
Onzeald
Europe
Daiichi Sankyo